CLDN7 and cancer: A recently study by Thuma and colleagues further reported that nonpalmitoylated CLDN7 is required for the formation of intercellular TJs as a TJ protein, as well as inhibiting the tumor metastasis via cytoskeletal keratin and myosin association with EpC, a cancer-initiating cells marker.